Fennec Pharmaceuticals Inc.

US$9.81As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:FENCHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 17.14%
Div yield —
ROE (18.58%)
Biotechnology
Beta (5Y) 1.21
PE TTM —
TSR TTM 19.63%
Mkt cap US$344.0M
ROIC (2.59%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$11
16.63%
18.39%
Hold 11|10|7|12|6
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.16
0.17
0.18
0.18
27.76%
28.75%
23.64%
18.68%
Revenue$M
44.69
46.50
48.93
47.62
8.20%
14.45%
15.81%
6.59%
Peers (US$344.0M)
Cap (US$)
PE
344.6M
—
340.9M
6.177x
Capital
TTM
5Y
10Y
Leveragex
1.062
0.037
0.035
EBIT/Intx
1.428
0.170
0.164
Own earn%
27.37
144.38
134.86
Sh yield%
36.54
23.36
24.60
Owners
Insiders/Inst%
14.77
31.75
Short interest%
3.37
SBC / revenue%
1.10
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
16–26
$1 testx
0.0
Incr. ROIC%
7